Drugs Information:
Palifermin
Basic Information
|
||
| ID | DDInter1380 | |
| Drug Type | biotech | |
| Protein Chemical Formula | C721H1142N202O204S9 | |
| Protein Average Weight | 16192.700 | |
| CAS Number | 162394-19-6 | |
| Description | Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli. Palifermin was granted FDA approval on 15 December 2004.[L17933] | |
| ATC Classification | V03AF08 | |
| Sequences | >Palifermin sequence MSYDYMEGGDIRVRRLFCRTQWYLRIDKRGKVKGTQEMKNNYNIMEIRTVAVGIVAIKGV ESEFYLAMNKEGKLYAKKECNEDCNFKELILENHYNTYASAKWTHNGGEMFVALNQKGIP VRGKKTKKEQKTAHFLPMAIT | |
| Useful Links | DrugBank PubChem Substance PharmGKB UniProtKB Therapeutic Targets Database Wikipedia ChEMBL | |
Interactions with
Palifermin
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|